Transmedics Group Inc reports results for the quarter ended June 30 - Earnings Summary

TransMedics

04/08/2026 22:37

Transmedics Group Inc TMDX.OQ reported quarterly adjusted earnings of 44 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 92 cents.  The mean expectation of twelve analysts for the quarter was for earnings of 47 cents per share. Wall Street expected results to range from 33 cents to 55 cents per share.
Revenue rose 20.7% to $189.95 million from a year ago; analysts expected $183.64 million. 
Transmedics Group Inc's reported EPS for the quarter was 41 cents​.
The company reported quarterly net income of $14.68 million.
Transmedics Group Inc shares had risen by 22.8% this quarter and lost 33.0% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 30.3% in the last three months.​ 
In the last 30 days, four analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy" 
Wall Street's median 12-month price target for Transmedics Group Inc is $120.00, about 32% above its last closing price of $81.55
This summary was machine generated from LSEG data August 4 at 09:37 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
0.47
0.44
Missed
Mar. 31 2026 
0.61
0.30
Missed
Dec. 31 2025 
0.39
0.53
Beat
Sep. 30 2025 
0.35
0.66
Beat